SHRED maximizes the fat tissue reduction process and optimizes metabolism through the synergistic action of three active compounds - enhances fat burning and preserves muscle tissue. Choose Powerock Pharma for certified quality and documented research results.
SHRED (RAD140+GW501516+S4) is an advanced research compound created for studies on fat tissue metabolism and physical performance. This substance combines three active components: RAD-140 (10mg), GW-501516 (15mg), and Andarine (25mg), designed for research on fat metabolism and muscle tissue behavior. This unique compound complex works by selectively modulating specific receptors, making it a valuable tool in research on metabolic processes.
Discover the potential laboratory properties of SHRED that may support research on metabolism and physical performance.
Supports processes related to fat tissue metabolism in laboratory conditions.
Allows for studying muscle tissue behavior processes.
Selectively interacts with specific receptors in tissues.
Enables studying the impact on physical performance.
Ensures accurate results in laboratory conditions.
Combines the action of three research compounds.
Produced according to GMP, HACCP, and ISO 13485 standards.
Precisely targets specific metabolic pathways.
At Powerock Pharma, our priority is to deliver only the highest quality research substances. Every batch of SHRED is manufactured in facilities compliant with GMP, HACCP, and ISO 13485 standards. Our strict quality control oversight and use of the latest testing procedures ensure not only effectiveness of the products but also their safety and reliability. We collaborate with leading laboratories to ensure purity and efficacy of the substances, guaranteeing consistent and repeatable results. By choosing Powerock Pharma, you are opting for excellence, safety, and unmatched quality of research materials.
SHRED should be administered according to the research protocol. For precise calculation of the required amounts for research, we recommend using the dosage calculator.
To maintain consistency in the studies, it is recommended to administer the substance at regular 12-hour intervals according to the research protocol.
The suggested research period is 8-12 weeks for accurate result monitoring, followed by a 4-week break.
For subjects with lower body weight, a dose of 50mg per day is recommended, with the possibility of adjustment.
For subjects with higher body weight, the suggested dose is 100mg per day (50mg in the morning and 50mg in the evening).
Regular monitoring of biochemical parameters, body composition, and performance markers is essential.
Tip: 1 MG = 1000 MCG
